Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Published in: Journal of Inherited Metabolic Disease 6/1998

01-08-1998

3-Methylglutaconic aciduria associated with hepatosplenomegaly, macrocytic anaemia, fever episodes, recurrent infections, cervical lymphadenopathy and progressive decrease of physical performance

Authors: M. H. Holtmann, P. R. Galle, W. Stremmel, E. Mayatepek

Published in: Journal of Inherited Metabolic Disease | Issue 6/1998

Login to get access
Metadata
Title
3-Methylglutaconic aciduria associated with hepatosplenomegaly, macrocytic anaemia, fever episodes, recurrent infections, cervical lymphadenopathy and progressive decrease of physical performance
Authors
M. H. Holtmann
P. R. Galle
W. Stremmel
E. Mayatepek
Publication date
01-08-1998
Publisher
Kluwer Academic Publishers
Published in
Journal of Inherited Metabolic Disease / Issue 6/1998
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1023/A:1005449004505

Other articles of this Issue 6/1998

Journal of Inherited Metabolic Disease 6/1998 Go to the issue

OriginalPaper

Commentary: Neonatal onset in fatty acid oxidation disorders: How can we minimize morbidity and mortality?

Legacy

Homocystinuria (methylenetetrahydrofolate reductase deficiency) and mutation of factor V gene

OriginalPaper

Hunter disease in the Spanish population: Molecular analysis in 31 families

Legacy

MS-PCR assay to detect 677C→T mutation in the 5,10-methylenetetrahydrofolate reductase gene

OriginalPaper

Variable clinical presentation in three patients with 3-methylglutaconyl-coenzyme A hydratase deficiency

OriginalPaper

Methylmalonic acidaemia with bilateral globus pallidus involvement: A neuropathological study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits